Skip to Content

Health

Death under investigation is ‘potentially associated’ with recalled Diamond Shruumz edibles, FDA says

By Maya Davis, CNN (CNN) — The US Food and Drug Administration says there is a “potentially associated death” under investigation that may be linked to microdosing products from Diamond Shruumz. The products have been associated with 48 illnesses in 24 states, the FDA said Tuesday. All but two of the people sought medical care, and 27 were hospitalized.

Continue Reading

FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease

By Jen Christensen, CNN (CNN) — The US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to slow the progression of early symptomatic Alzheimer’s disease. Donanemab, made by Indianapolis-based Eli Lilly, works by helping the body remove amyloid plaque buildup in the brain, a hallmark of Alzheimer’s disease. Lilly said it

Continue Reading

Some antidepressants contribute to weight gain more than others, study finds

By Sandee LaMotte, CNN (CNN) — Antidepressants can be lifesavers for many struggling with so many mental health diagnoses — anxiety, depression, obsessive-compulsive disorder, panic disorder, social phobias and post-traumatic stress disorder. Yet taking these mood-altering substances can lead to an unpleasant side effect for some — weight gain. While many people never add extra

Continue Reading

In new Alzheimer’s criteria, some see progress while others fear profit-driven ‘diagnostic creep’

By Brenda Goodman, CNN (CNN) — Editor’s note: “Dr. Sanjay Gupta Reports: The Last Alzheimer’s Patient” airs at 8 p.m. ET Sunday, July 7, on CNN. With another pricey Alzheimer’s disease treatment expected to receive an approval decision soon, the nonprofit Alzheimer’s Association has published the final version of its new diagnostic criteria for the disease.

Continue Reading